Swiss Luxury Stock News

Logitech International (SWX:LOGN) is back in focus after management highlighted firm demand for premium peripherals and enterprise video collaboration, growing China gaming sales, secured memory supply into fiscal 2027, and continued share repurchases and dividend increases. See our latest analysis for Logitech International. At a share price of CHF71.1, Logitech has seen a 2.3% 1 day and 2.3% 7 day share price gain, set against a 90 day share price decline of 21.3% and a 1 year total...

DKSH Holding (SWX:DKSH) has drawn fresh attention after reporting full year 2025 earnings, which showed slightly lower sales and net income, along with board changes and a confirmed CHF 2.50 per share annual dividend. See our latest analysis for DKSH Holding. Against this backdrop, DKSH Holding’s 30 day share price return of 9.28% and 90 day share price return of 11.23% contrast with a 1 year total shareholder return of 9.53% and 3 year total shareholder return of 12.13%. This suggests recent...

Novartis (SWX:NOVN) plans to build a new radioligand therapy manufacturing facility in Denton, Texas. The plant will expand US production capacity for next generation cancer treatments. The project is expected to create specialized jobs and support a more resilient domestic supply chain. For you as an investor, this move highlights how Novartis is leaning further into radioligand therapies, a targeted cancer treatment area that has drawn growing interest in oncology. The Denton site adds to...

Amrize (SWX:AMRZ) has appointed Ernst & Young LLP (EY US) as its new independent registered public accounting firm, moving from EY Switzerland. The company has reshaped its board structure, including naming a new Chair for the Audit Committee and adding a board member with audit expertise. These governance changes focus on audit oversight, internal controls and financial reporting processes. For investors watching Amrize at a share price of CHF49.27, the shift to EY US and the refreshed...

Schindler Holding AG has reported full-year 2025 results, with sales of CHF 10,947 million and net income of CHF 1,015 million, and has approved an annual dividend of CHF 6.00 per share payable on March 30, 2026. The combination of higher net income and earnings per share, despite slightly lower sales, alongside the confirmed cash return to shareholders, underlines the group’s ability to convert revenue into profit and maintain shareholder distributions. Against this backdrop of higher...

Earnings and dividend move into focus ALSO Holding (SWX:ALSN) reported full year 2025 results with sales of €13,501.23m and net income of €109.33m, alongside a higher annual dividend of CHF 5.30 per share. See our latest analysis for ALSO Holding. The earnings release, dividend increase and earnings call arrived after a tough stretch for shareholders, with the 1 year total shareholder return at a 40.5% loss and the year to date share price return at a 24.7% loss. However, the 7 day share...

ABB (SWX:ABBN) is expanding its robotics and automation operations in China to serve rising demand for Automated Guided Vehicles (AGVs) in logistics and manufacturing. The company is targeting the fast growing e commerce and warehouse automation market, where AGVs support high volume order fulfillment and material handling. This move focuses on integrating AI, IoT, and Industry 4.0 capabilities into AGVs for Chinese customers. For you as an investor, this development sits at the...

Georg Fischer FY 2025 earnings snapshot Georg Fischer (SWX:GF) has opened FY 2025 with first half revenue of CHF2.3b and basic EPS of CHF1.95, alongside net income excluding extra items of CHF160m, setting a clear marker for its latest performance. The company has seen first half revenue shift from CHF1.96b in 2023 to CHF2.41b in 2024 and then to CHF2.26b in 2025, while basic EPS moved from CHF1.50 to CHF1.18 and then to CHF1.95 over the same periods. This gives investors a clearer view of...

Sandoz Group (SWX:SDZ) has drawn fresh attention after reporting full year 2025 earnings, with sales of US$11,086 million and net income of US$914 million, alongside progress in its expanding biosimilars portfolio. See our latest analysis for Sandoz Group. Sandoz Group's 1 day share price return of 2.87% contrasts with a 7 day share price return of 4.64% and a 90 day share price return of 24.01%. The 1 year total shareholder return of 80.41% points to strong momentum around its biosimilars...

Latest earnings snapshot Walliser Kantonalbank (SWX:WKBN) has just posted FY 2025 numbers, with first half revenue of CHF 135.7m and net income (excluding extra items) of CHF 61.0m. This helps indicate how its profitability is holding up. The bank has seen revenue move from CHF 140.7m in 1H 2024 to CHF 154.1m in 2H 2024, and then to CHF 135.7m in 1H 2025. Over the same periods, net income shifted from CHF 66.0m to CHF 69.4m, and then to CHF 61.0m. These figures give investors a clearer view...

Adecco Group (SWX:ADEN) lays out its FY 2025 scorecard Adecco Group (SWX:ADEN) has put its FY 2025 numbers on the table, with fourth quarter revenue of €5.96b, basic EPS of €0.52 and net income of €88m, alongside trailing twelve month revenue of €23.08b and basic EPS of €1.76. Over recent periods the company has seen quarterly revenue move between €5.57b and €5.96b, while basic EPS has ranged from €0.35 to €0.59 and trailing twelve month EPS has sat between €1.67 and €1.81. This gives...

Partners Group Holding (SWX:PGHN) plans to open an office in Kuwait, subject to regulatory approval. The move is intended to expand the firm's presence across the Gulf Cooperation Council region. The new office is expected to support local economic diversification efforts and private markets activity. Partners Group is a global private markets investment firm, and the Kuwait office fits into its broader push to be closer to large institutional and sovereign clients in the Gulf. For...

UBS Group (SWX:UBSG) has promoted Lisa Golia to oversee U.S. financial advisors within its Global Wealth Management division. The bank has also rehired Andrew Bird as head of global wealth management in Australia. UBS Global Research is flagging growing risks in private credit markets linked to AI driven disruption, with expectations for higher default rates and wider credit spreads. For you as an investor, these moves sit at the heart of what UBS does: advising and managing money for...

Temenos (SWX:TEMN) has wrapped up FY 2025 with fourth quarter revenue of US$314.6 million and basic EPS of US$0.63, rounding out a trailing twelve month picture that includes revenue of about US$1.1 billion and EPS of US$4.06. Over the past six quarters, revenue has moved between US$232.2 million and US$318.9 million while quarterly EPS ranged from US$0.41 to US$2.34, giving you a clear view of how top line and per share earnings have tracked together through the latest cycle. With a trailing...

Logitech International highlighted steady demand for high end peripherals and enterprise video collaboration products, even as gaming demand differs by region. Management pointed to stronger gaming activity in China alongside softer trends in North America, underscoring mixed regional consumer patterns. The company outlined supply chain plans and reiterated a focus on capital deployment, including M&A and a sizeable share repurchase program. For investors watching SWX:LOGN, the latest...

Julius Bär Gruppe (SWX:BAER) has appointed Winfried Daun as Global Head of Brand & Marketing in a newly created leadership role. The company has introduced new model portfolios for UK financial advisers as part of an expanded UK wealth management approach. Julius Bär Gruppe, a Swiss private banking group, focuses on wealth management services for high net worth and ultra high net worth clients. The new marketing appointment and the UK model portfolios arrive as many wealth managers look to...

How OC Oerlikon’s FY 2025 Results Line Up With The Market Narrative OC Oerlikon (SWX:OERL) opened FY 2025 with first half revenue of CHF 786 million and a basic EPS loss of CHF 0.14, highlighting that profitability remains under pressure even as discontinued operations contributed CHF 16 million. The company has seen revenue move from CHF 835 million in the first half of 2024 to CHF 1,206 million in the second half of 2024, while EPS shifted from CHF 0.06 to CHF 0.09 over the same periods,...

PSP Swiss Property (SWX:PSPN) has put out its FY 2025 numbers with fourth quarter revenue of CHF 99.5m and basic EPS of CHF 3.25, while the trailing twelve months show revenue of CHF 362.2m and basic EPS of CHF 8.91 alongside year on year earnings growth of 8.9%. Over recent periods, the company has seen quarterly revenue move from CHF 88.6m and EPS of CHF 3.25 in Q4 2024 to CHF 99.5m and EPS of CHF 3.25 in Q4 2025. This is set against a five year EPS trend that declined about 7% a year,...

Alcon FY 2025 earnings: revenue push with mixed profit signals Alcon (SWX:ALC) has wrapped up FY 2025 with fourth quarter revenue of US$2.7 billion and basic EPS of US$0.44, alongside trailing 12 month revenue of US$10.4 billion and basic EPS of US$1.99 that frame the latest print against a fuller year of performance. The company has seen quarterly revenue move from US$2.5 billion in Q4 2024 to US$2.7 billion in Q4 2025, while basic EPS shifted from US$0.57 to US$0.44 over the same period...

Dormakaba Holding (SWX:DOKA) has kicked off H1 2026 with revenue of CHF1.4b and basic EPS of CHF0.97, alongside net income of CHF40.5m, as investors weigh those figures against a year that saw earnings grow 30% and net profit margin reach 3.1%. Over the last three reported half years, revenue has moved from CHF1.4b in H1 2025 to CHF1.4b in H2 2025 and then to CHF1.4b in H1 2026. Over the same period, basic EPS has shifted from CHF1.20 to CHF1.14 and now CHF0.97, providing a clear view of how...

Roche Holding (SWX:ROG) reported that the US FDA accepted its New Drug Application for giredestrant, an oral therapy candidate for advanced ER-positive, ESR1-mutated breast cancer. The company also released positive phase III MAJESTY trial results for Gazyva/Gazyvaro in primary membranous nephropathy. Both developments relate to conditions with high unmet medical need and could influence future treatment options in oncology and nephrology. Roche, known for its focus on oncology and...

Holcim earnings in focus Holcim (SWX:HOLN) heads into its 27 February 2026 earnings release with investors watching closely for margin guidance, cement pricing updates, regional demand commentary, and any signals around near term stock volatility. See our latest analysis for Holcim. Holcim’s 1 day share price return of 1.12% and 7 day share price return of 4.77% contrast with a 30 day share price decline of 4.74%. At the same time, a 1 year total shareholder return of 60.63% and 3 year total...

SoftwareOne Holding (SWX:SWON) is in focus after announcing it has become one of the first global authorized Google Cloud distributors. The company will extend access to Google Cloud products across 10 initial launch markets. See our latest analysis for SoftwareOne Holding. The announcement comes after a tough stretch for the stock, with a 30 day share price return of a 20.76% decline and a year to date share price return of a 26.16% decline, while the 1 year total shareholder return of 8.43%...

Nestlé (SWX:NESN) is in advanced talks to sell its ice cream business as part of a CEO led turnaround plan. The company has also begun a sale process for its waters and drinks division, pointing to a potential exit from sizeable parts of its portfolio. These moves follow pressure on profits linked to baby formula recalls and increasing demands from shareholders for change. Nestlé is one of the largest global consumer packaged food companies, with brands across coffee, pet care,...